Vericel Corporation (VCEL) Financials

VCEL Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 353.7 million 127.7 million
2023-09-30 318.1 million 113.7 million
2023-06-30 310.7 million 111.8 million
2023-03-31 265.1 million 71.1 million

VCEL Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 6.8 million 6.9 million
2023-09-30 600000 7.9 million
2023-06-30 6.0 million 8.8 million
2023-03-31 -1.1 million 8.7 million

VCEL Net Income

No data available :(

VCEL Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 109.6 million - 88.0 million
2023-09-30 105.3 million - 85.1 million
2023-06-30 97.8 million - 83.4 million
2023-03-31 119.3 million - 46.9 million

VCEL Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 50.5 million
2023-09-30 47.6 million
2023-06-30 47.6 million
2023-03-31 47.4 million

VCEL Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 7.8 million 4.9 million 30.9 million -
2023-09-30 6.6 million 5.7 million 30.0 million -
2023-06-30 4.2 million 5.3 million 30.6 million -
2023-03-31 8.9 million 5.2 million 29.5 million -

VCEL Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 65.0 million 16.5 million
2023-09-30 45.6 million 15.0 million
2023-06-30 45.9 million 16.0 million
2023-03-31 41.0 million 14.5 million

VCEL

Price: $47.83

52 week price:
29.24
53.05

Payout Ratio Range:
-430000.00%
15925.93%

Earnings Per Share: -0.07 USD

P/E Ratio: -218.33

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 122353

Ebitda: -4.7 million

Market Capitalization: 2.4 billion

Links: